公司資料
Veracyte 股價、新聞與催化劑
- 股票代碼:
- VCYT
- 交易所:
- NASDAQ
- 產業:
- MedTech
- 所在地:
- United States
股票表現
42.08 USD (+2.01%)
收盤價
最後更新: 2026年8月17日
3.81B USD
市值
股價為何變動
As of Aug 17, 2026, VCYT closed up 2.01% at $42.08. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
Veracyte is a diagnostics company focused on genomic testing for cancer and other high-value clinical decisions. Its products help physicians make more informed treatment and biopsy decisions.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ, Veracyte sits in molecular diagnostics and precision medicine.
商業模式特徵
The company depends on test volume, reimbursement, and the expansion of its oncology and pulmonary diagnostics franchises.
生技產業定位
Veracyte is a diagnostics platform name whose stock moves more on adoption and reimbursement than on drug-development catalysts.
未來催化劑
- Veracyte's catalysts are Afirma, Decipher, and broader lung and bladder diagnostics adoption. The company improves when recurring testing and reimbursement keep expanding.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。